Chung L, Berry G J, Chakravarty E F
Division of Immunology and Rheumatology, Department of Medicine, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
Lupus. 2005;14(2):166-9. doi: 10.1191/0961203305lu2040cr.
Giant cell myocarditis (GCM) is a rare form of myocarditis with a median survival of less than one year. It has been reported to occur in patients with various underlying autoimmune diseases; however, no cases of GCM have been described in patients with clear evidence of underlying systemic lupus erythematosus (SLE). The presentation of GCM may mimic that of lupus myocarditis, including an initial response to immunosuppression. Despite initial clinical similarities, lupus myocarditis and GCM are histologically distinct entities with dramatic differences in prognosis. We report herein a patient with a longstanding history of SLE, who presented acutely with myocarditis, responded well to initial immunosuppression and then subsequently died of progressive heart failure that was found to be due to GCM. Endomyocardial biopsy can help define diagnosis and prognosis of lupus patients presenting with myocarditis, and early referral for cardiac transplantation should be considered in patients diagnosed with GCM.
巨细胞性心肌炎(GCM)是一种罕见的心肌炎形式,中位生存期不到一年。据报道,它发生于患有各种潜在自身免疫性疾病的患者中;然而,尚无明确证据表明患有系统性红斑狼疮(SLE)的患者出现GCM的病例。GCM的表现可能与狼疮性心肌炎相似,包括对免疫抑制的初始反应。尽管最初在临床上有相似之处,但狼疮性心肌炎和GCM在组织学上是不同的实体,预后有显著差异。我们在此报告一名有长期SLE病史的患者,该患者急性出现心肌炎,对初始免疫抑制反应良好,但随后死于进行性心力衰竭,经发现是由GCM所致。心内膜活检有助于明确患有心肌炎的狼疮患者的诊断和预后,对于诊断为GCM的患者应考虑早期转诊进行心脏移植。